Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

Conditions:   Neoadjuvent;   PD-1 Inhibitor;   Chemotherapy;   Esophageal Squamous Cell Carcinoma Intervention:   Drug: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin Sponsor:   Tang-Du Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials